XML 11 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Gain (Loss) [Member]
Beginning balance at Dec. 31, 2022 $ 110,903 $ 43 $ 262,496 $ (151,605) $ (31)
Beginning balance, shares at Dec. 31, 2022   43,269,200      
Stock-based compensation expense 1,833   1,833    
Unrealized gain (loss) on marketable securities 31       31
Net loss (6,526)     (6,526)  
Ending balance at Mar. 31, 2023 106,241 $ 43 264,329 (158,131)  
Ending balance, shares at Mar. 31, 2023   43,269,200      
Beginning balance at Dec. 31, 2022 110,903 $ 43 262,496 (151,605) (31)
Beginning balance, shares at Dec. 31, 2022   43,269,200      
Unrealized gain (loss) on marketable securities 38        
Net loss (23,956)        
Ending balance at Sep. 30, 2023 92,712 $ 43 268,223 (175,561) 7
Ending balance, shares at Sep. 30, 2023   43,905,903      
Beginning balance at Mar. 31, 2023 106,241 $ 43 264,329 (158,131)  
Beginning balance, shares at Mar. 31, 2023   43,269,200      
Stock-based compensation expense 2,043   2,043    
Unrealized gain (loss) on marketable securities 12       12
Net loss (8,366)     (8,366)  
Ending balance at Jun. 30, 2023 99,930 $ 43 266,372 (166,497) 12
Ending balance, shares at Jun. 30, 2023   43,269,200      
Exercise of stock options 24   24    
Exercise of stock options, shares   8,300      
Stock-based compensation expense 1,821   1,821    
Exercise of warrants 6   6    
Exercise of warrants, shares   628,403      
Unrealized gain (loss) on marketable securities (5)       (5)
Net loss (9,064)     (9,064)  
Ending balance at Sep. 30, 2023 92,712 $ 43 268,223 (175,561) 7
Ending balance, shares at Sep. 30, 2023   43,905,903      
Beginning balance at Dec. 31, 2023 81,720 $ 43 270,150 (188,554) 81
Beginning balance, shares at Dec. 31, 2023   43,909,069      
Issuance of common stock, net 161,756 $ 20 161,736    
Issuance of common stock, net, shares   19,736,842      
Vesting of restricted stock units   $ 1 (1)    
Vesting of restricted stock units, shares   153,750      
Exercise of stock options, shares   356      
Stock-based compensation expense 2,128   2,128    
Unrealized gain (loss) on marketable securities (106)       (106)
Net loss (14,654)     (14,654)  
Ending balance at Mar. 31, 2024 230,844 $ 64 434,013 (203,208) (25)
Ending balance, shares at Mar. 31, 2024   63,800,017      
Beginning balance at Dec. 31, 2023 $ 81,720 $ 43 270,150 (188,554) 81
Beginning balance, shares at Dec. 31, 2023   43,909,069      
Exercise of stock options, shares 6,967        
Unrealized gain (loss) on marketable securities $ 277        
Net loss (51,780)        
Ending balance at Sep. 30, 2024 198,400 $ 64 438,312 (240,334) 358
Ending balance, shares at Sep. 30, 2024   63,806,628      
Beginning balance at Mar. 31, 2024 230,844 $ 64 434,013 (203,208) (25)
Beginning balance, shares at Mar. 31, 2024   63,800,017      
Exercise of stock options 11   11    
Exercise of stock options, shares   2,500      
Stock-based compensation expense 2,301   2,301    
Unrealized gain (loss) on marketable securities (125)       (125)
Net loss (21,627)     (21,627)  
Ending balance at Jun. 30, 2024 211,404 $ 64 436,325 (224,835) (150)
Ending balance, shares at Jun. 30, 2024   63,802,517      
Exercise of stock options 30   30    
Exercise of stock options, shares   4,111      
Stock-based compensation expense 1,957   1,957    
Unrealized gain (loss) on marketable securities 508       508
Net loss (15,499)     (15,499)  
Ending balance at Sep. 30, 2024 $ 198,400 $ 64 $ 438,312 $ (240,334) $ 358
Ending balance, shares at Sep. 30, 2024   63,806,628